Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Innovative Pharmaceutical Biotech ( (HK:0399) ) has shared an announcement.
Starcoin Group Limited has announced a memorandum of understanding with Starcoin Foundation to issue Starcoin Tokens, marking the first ‘token-stock linkage’ project initiated by a publicly traded company in Asia. This initiative aims to establish a foundational platform for the global Web3 digital capital market, leveraging blockchain technology to create an integrated on-chain investment banking system focused on the issuance and circulation of Real World Assets (RWA). The project, which will be deployed on the Conflux eSpace public blockchain, seeks to position the company as a key link between global assets and digital investors.
More about Innovative Pharmaceutical Biotech
Starcoin Group Limited, formerly known as Innovative Pharmaceutical Biotech Limited, is an investment holding company incorporated in the Cayman Islands and continued in Bermuda with limited liability. The company and its subsidiaries primarily engage in the trading of beauty equipment and products in Hong Kong, as well as the research, development, and commercialization of oral insulin products.
Average Trading Volume: 25,660,933
Technical Sentiment Signal: Buy
Current Market Cap: HK$653.6M
Learn more about 0399 stock on TipRanks’ Stock Analysis page.